Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Finished Goods (2017 - 2025)

Nephros (NEPH) has 9 years of Finished Goods data on record, last reported at $2.5 million in Q3 2025.

  • For Q3 2025, Finished Goods fell 7.36% year-over-year to $2.5 million; the TTM value through Sep 2025 reached $2.5 million, down 7.36%, while the annual FY2024 figure was $2.3 million, 5.46% up from the prior year.
  • Finished Goods reached $2.5 million in Q3 2025 per NEPH's latest filing, up from $2.0 million in the prior quarter.
  • Across five years, Finished Goods topped out at $4.2 million in Q2 2021 and bottomed at $1.6 million in Q1 2025.
  • Average Finished Goods over 5 years is $2.7 million, with a median of $2.5 million recorded in 2025.
  • Peak YoY movement for Finished Goods: plummeted 54.0% in 2023, then soared 44.15% in 2024.
  • A 5-year view of Finished Goods shows it stood at $3.7 million in 2021, then dropped by 25.88% to $2.7 million in 2022, then decreased by 20.86% to $2.1 million in 2023, then increased by 5.46% to $2.3 million in 2024, then increased by 11.85% to $2.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Finished Goods were $2.5 million in Q3 2025, $2.0 million in Q2 2025, and $1.6 million in Q1 2025.